Utility of ctDNA-molecular residual disease in predicting minimal residual disease in non-small cell lung cancer patients after radical resection.

ABSTRACT:

SUBMITTER: Masago K 

PROVIDER: S-EPMC12541828 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature